MINAPHARM Pharmaceuticals Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3,430	2,885	1,918	1,694	981.94
Short-Term Investments	-	5	-	-	-
Cash & Short-Term Investments	3,430	2,890	1,918	1,694	981.94
Cash Growth	18.66%	50.70%	13.25%	72.47%	-4.06%
Accounts Receivable	509.58	647.52	492.9	478.14	388.76
Other Receivables	0.99	5.83	46.13	12.22	5.52
Receivables	654.72	934.67	742.76	575.06	399.59
Inventory	1,495	1,233	1,055	838.28	668.51
Prepaid Expenses	41.07	30.33	10.76	12.41	6.54
Other Current Assets	632.51	629.14	315.92	524.8	345.77
Total Current Assets	6,253	5,717	4,042	3,644	2,402
Property, Plant & Equipment	6,154	5,687	4,251	2,685	1,340
Long-Term Investments	5	-	5	5	5
Goodwill	355.35	339.97	334.51	280.08	220.53
Other Intangible Assets	375.91	254.84	67.1	56.9	48.2
Long-Term Deferred Tax Assets	-	7.02	-	-	-
Other Long-Term Assets	5.22	4.92	3.22	134.67	89.77
Total Assets	13,148	12,010	8,704	6,806	4,106
Accounts Payable	1,191	1,222	707.54	677.29	416.64
Accrued Expenses	109.9	47.34	46.81	39.23	31.53
Short-Term Debt	2,021	2,312	2,071	1,042	542.29
Current Portion of Long-Term Debt	706.58	398.09	218.67	225.33	32.93
Current Portion of Leases	49.42	55.35	27.77	15.1	68.13
Current Income Taxes Payable	255.06	195.94	134.82	233.36	183.69
Current Unearned Revenue	17.25	14.62	9.81	7.45	5.04
Other Current Liabilities	457.44	495.28	314.7	261.3	208.89
Total Current Liabilities	4,807	4,740	3,531	2,501	1,489
Long-Term Debt	1,503	2,250	1,335	1,036	603.87
Long-Term Leases	260.05	562.68	153.62	114.83	1.17
Long-Term Unearned Revenue	194.97	167.5	-	-	-
Long-Term Deferred Tax Liabilities	24.86	-	44.99	56.01	22.69
Other Long-Term Liabilities	-	-	121.15	57.52	45.73
Total Liabilities	6,790	7,720	5,186	3,765	2,163
Common Stock	117.81	117.81	122.93	122.93	122.93
Retained Earnings	4,086	1,934	2,147	2,023	1,466
Treasury Stock	-	-	-69.63	-69.63	-
Comprehensive Income & Other	2,047	2,135	1,222	882.83	293.27
Total Common Equity	6,251	4,187	3,423	2,959	1,882
Minority Interest	107.76	102.74	94.61	81.82	61.29
Shareholders' Equity	6,358	4,290	3,517	3,041	1,943
Total Liabilities & Equity	13,148	12,010	8,704	6,806	4,106
Total Debt	4,540	5,578	3,806	2,433	1,248
Net Cash (Debt)	-1,110	-2,688	-1,889	-739.64	-266.46
Net Cash Per Share	-100.33	-242.93	-170.70	-64.46	-21.67
Filing Date Shares Outstanding	11.78	11.78	11.06	11.06	12.29
Total Common Shares Outstanding	11.78	11.78	11.06	11.06	12.29
Working Capital	1,446	976.61	511.26	1,143	913.2
Book Value Per Share	530.56	355.43	309.35	267.42	153.07
Tangible Book Value	5,519	3,592	3,021	2,622	1,613
Tangible Book Value Per Share	468.49	304.94	273.05	236.96	131.21
Land	57.96	55.2	39.7	33.23	26.15
Buildings	1,701	1,579	508.65	411.79	296.6
Machinery	3,246	2,505	1,777	1,365	977.94
Construction In Progress	2,924	2,988	2,936	1,666	666.97